Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases

Fig. 1

Comparison of intracranial local tumour control (LTC) (A), intracranial progression-free survival (PFS) (B), and overall survival (OS) (C) between whole brain radiation therapy with a simultaneous integrated boost (WBRT + SIB) and whole brain radiation therapy (WBRT) in all patients using competing risk analyses. Comparison of intracranial LTC (D), intracranial PFS (E), and OS (F) between WBRT + SIB and WBRT after propensity score matching (PSM) using competing risk analyses. Comparison of intracranial LTC (G), intracranial PFS (H), and OS (I) between WBRT + SIB and WBRT in the lung cancer subgroup using competing risk analyses

Back to article page